Ocular Therapeutix Inc (OCUL)
6.12
-0.17
(-2.70%)
USD |
NASDAQ |
May 21, 12:49
Ocular Therapeutix Cash from Financing (TTM): 490.97M for March 31, 2024
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 490.97M |
December 31, 2023 | 169.83M |
September 30, 2023 | 62.12M |
June 30, 2023 | 10.56M |
March 31, 2023 | 1.403M |
December 31, 2022 | 1.454M |
September 30, 2022 | 1.663M |
June 30, 2022 | 1.968M |
March 31, 2022 | 4.142M |
December 31, 2021 | 2.851M |
September 30, 2021 | 166.10M |
June 30, 2021 | 165.64M |
March 31, 2021 | 214.03M |
December 31, 2020 | 228.01M |
September 30, 2020 | 73.19M |
June 30, 2020 | 91.58M |
March 31, 2020 | 45.86M |
December 31, 2019 | 75.34M |
September 30, 2019 | 82.58M |
June 30, 2019 | 75.34M |
March 31, 2019 | 76.71M |
Date | Value |
---|---|
December 31, 2018 | 68.64M |
September 30, 2018 | 53.52M |
June 30, 2018 | 43.67M |
March 31, 2018 | 37.76M |
December 31, 2017 | 32.01M |
September 30, 2017 | 31.50M |
June 30, 2017 | 30.04M |
March 31, 2017 | 29.25M |
December 31, 2016 | 0.585M |
September 30, 2016 | 0.20M |
June 30, 2016 | -0.079M |
March 31, 2016 | 65.65M |
December 31, 2015 | 65.70M |
September 30, 2015 | 65.29M |
June 30, 2015 | 133.04M |
March 31, 2015 | 79.27M |
December 31, 2014 | 78.97M |
September 30, 2014 | 78.63M |
June 30, 2014 | 10.62M |
March 31, 2014 | 6.705M |
December 31, 2013 | 6.683M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
1.403M
Minimum
Mar 2023
490.97M
Maximum
Mar 2024
98.23M
Average
74.27M
Median
Cash from Financing (TTM) Benchmarks
Amgen Inc | -2.169B |
Assertio Holdings Inc | -25.46M |
CytomX Therapeutics Inc | 30.40M |
EyePoint Pharmaceuticals Inc | 192.30M |
Cormedix Inc | 48.62M |